Roxadustat for heart and nutrition in dialysis patients
Treatments studied
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether roxadustat can help improve heart health, nutrition, and reduce inflammation in people on hemodialysis. It may offer a new treatment option for anemia related to kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been on dialysis for more than 3 months.
- You are not pregnant or breastfeeding.
- You do not have cancer, a blood disorder, or another cause of anemia besides kidney disease.
- You do not have severe heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
This study tests an investigational drug (RVX000222) to see if it helps people with kidney failure who are on dialysis. The drug is given in two parts and may help improve heart health, which is often a concern for dialysis patients.
This study looks at whether a drug called roxadustat helps people who have heart failure, anemia, and moderate-to-severe chronic kidney disease. The trial focuses on people who have already been taking roxadustat for more than a year.
This study tests whether a pill called roxadustat can help improve kidney oxygen levels in people with diabetes-related kidney disease and anemia. It may help boost your red blood cells and improve how your kidneys work.
This trial tests whether a drug called roxadustat (taken as a pill) can help people on dialysis who also have sarcopenia (loss of muscle strength and mass). It aims to see if the drug improves muscle health and anemia.
This trial tests a pill called roxadustat to help treat anemia in people with myelodysplastic syndromes (MDS). It might reduce the need for blood transfusions and improve energy levels.
Hear when a new Kidney Failure, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.